CD200-mediated AML resistance to T cell killing was observed both on CD4IL10 cells and primary human CD8+ T cells, and we show herein that ICAM1 expression on AML has a comparable effect on CD4IL10 cell and primary, ex vivo-isolated human CD8+ T cell function. This evidence concerns the gene CD8A and acute myeloid leukemia.